Literature DB >> 26754634

Toxic epidermal necrolysis in adult T cell leukemia/lymphoma treated with mogamulizumab.

Kazuna Tanba1,2, Nobuhiko Uoshima2, Hitoji Uchiyama2,3, Eri Kawata2, Reiko Isa2, Junko Yamaguchi2, Yasuhiko Tsutsumi2, Teruaki Akaogi2, Yutaka Kobayashi2, Kanade Katsura4, Junya Kuroda5, Masafumi Taniwaki1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26754634     DOI： 10.1007/s00277-016-2594-1

Source DB:  PubMed          Journal:  Ann Hematol        ISSN： 0939-5555            Impact factor:   3.673


× No keyword cloud information.
  2 in total

1.  Safety and efficacy of mogamulizumab in patients with adult T-cell leukemia-lymphoma in Japan: interim results of postmarketing all-case surveillance.

Authors:  Kenji Ishitsuka; Satoshi Yurimoto; Kouichi Kawamura; Yukie Tsuji; Manabu Iwabuchi; Takeshi Takahashi; Kensei Tobinai
Journal:  Int J Hematol       Date:  2017-06-09       Impact factor: 2.319

2.  Commentary to "Mogamulizumab-induced photosensitivity in patients with mycosis fungoides and other T-cell neoplasms" by Y. Masuda et al.

Authors:  H Hönigsmann
Journal:  J Eur Acad Dermatol Venereol       Date:  2018-10       Impact factor: 6.166
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.